全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Beyond the Tumor: Cutaneous Manifestations of Paraneoplastic Syndromes

DOI: 10.4236/jbm.2025.133018, PP. 229-242

Keywords: Paraneoplastic, Skin, Neoplasia, Oncology

Full-Text   Cite this paper   Add to My Lib

Abstract:

The skin is the most visible organ of the human body and the second largest, surpassed only by the endothelium. Its functions extend beyond aesthetics, as it is considered the primary protective barrier against external agents such as microorganisms, corrosive substances, ultraviolet radiation, and other harmful vectors. It also plays crucial roles in preventing total body water loss and regulating temperature. This physical, immunological, and chemical barrier is essential for homeostasis and overall well-being. Additionally, the skin can serve as an early indicator of underlying neoplasms, being the epicenter of multiple manifestations of paraneoplastic syndromes. These syndromes represent a heterogeneous group of clinical manifestations caused by the release of substances by tumor cells or the body’s immune response to them. Paraneoplastic skin manifestations, such as acanthosis nigricans, Leser-Trélat syndrome, or necrolytic migratory erythema, are examples of how the skin can reflect systemic alterations related to cancer. The importance of the skin in this context lies in its accessibility for clinical evaluation and its ability to provide critical diagnostic clues. An attentive physician can identify cutaneous signs that act as “red flags”, guiding early cancer detection and potentially improving patient prognosis. Therefore, the skin is not only a barrier but also a reflection of internal health, playing a vital role in diagnosing systemic diseases and clinical oncology.

References

[1]  Silva, J.A.D., Mesquita, K.D.C., Igreja, A.C.D.S.M., Lucas, I.C.R.N., Freitas, A.F., Oliveira, S.M.D., et al. (2013) Paraneoplastic Cutaneous Manifestations: Concepts and Updates. Anais Brasileiros de Dermatologia, 88, 9-22.
https://doi.org/10.1590/s0365-05962013000100001
[2]  Pelosof, L.C. and Gerber, D.E. (2010) Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment. Mayo Clinic Proceedings, 85, 838-854.
https://doi.org/10.4065/mcp.2010.0099
[3]  Henry, K. (2019) Paraneoplastic Syndromes: Definitions, Classification, Pathophysiology and Principles of Treatment. Seminars in Diagnostic Pathology, 36, 204-210.
https://doi.org/10.1053/j.semdp.2019.01.002
[4]  Badawy, M., Revzin, M.V., Consul, N., Soliman, M., Ganeshan, D.M., Heymann, J.C., et al. (2023) Paraneoplastic Syndromes from Head to Toe: Pathophysiology, Imaging Features, and Workup. RadioGraphics, 43, 1-18.
https://doi.org/10.1148/rg.220085
[5]  Aniyathodiyil, P.U. (2020) Von Hebra—Legend in dermatology. Journal of Skin and Sexually Transmitted Diseases, 2, 35-36.
https://doi.org/10.25259/jsstd_41_2019
[6]  Alter, M., Mengoni, M. and Gaffal, E. (2020) Cutaneous Manifestations of Internal Malignancy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 18, 456-469.
https://doi.org/10.1111/ddg.14093
[7]  Pipkin, C.A. and Lio, P.A. (2008) Cutaneous Manifestations of Internal Malignancies: An Overview. Dermatologic Clinics, 26, 1-15.
https://doi.org/10.1016/j.det.2007.08.002
[8]  Yuste-Chaves, M. and Unamuno-Pérez, P. (2013) Cutaneous Alerts in Systemic Malignancy: Part I. Actas Dermo-Sifiliográficas (English Edition), 104, 285-298.
https://doi.org/10.1016/j.adengl.2012.03.027
[9]  Al-Showbaki, L., Toubasi, A.A., Jaber, D.Z., Shdifat, M.A., Al-Maani, N., Qudah, O., et al. (2024) Paraneoplastic Cutaneous Manifestations of Hepatocellular Carcinoma. a Systematic Review and Meta-analysis. Journal of Cancer, 15, 1021-1029.
https://doi.org/10.7150/jca.88931
[10]  Vogrig, A., Gigli, G.L., Segatti, S., Corazza, E., Marini, A., Bernardini, A., et al. (2019) Epidemiology of Paraneoplastic Neurological Syndromes: A Population-Based Study. Journal of Neurology, 267, 26-35.
https://doi.org/10.1007/s00415-019-09544-1
[11]  Ionescu, V.A., Gheorghe, G., Georgescu, T.F., Buica, V., Catanescu, M., Cercel, I., et al. (2025) Cutaneous Paraneoplastic Syndromes in Colorectal Cancer Patients. Gastrointestinal Disorders, 7, Article 8.
https://doi.org/10.3390/gidisord7010008
[12]  Didona, D., Fania, L., Didona, B., Eming, R., Hertl, M. and Di Zenzo, G. (2020) Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis. International Journal of Molecular Sciences, 21, Article 2178.
https://doi.org/10.3390/ijms21062178
[13]  McCormick, B.J., Zieman, D., Sluzevich, J.C. and Alhaj Moustafa, M. (2024) Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin Lymphoma. Journal of Investigative Medicine High Impact Case Reports, 12, 1-5.
https://doi.org/10.1177/23247096241255840
[14]  González, L. and Peñaranda, E. (2010) Acantosis nigricans: Dos presentaciones de una misma enfermedad.
https://revista.asocolderma.org.co/index.php/asocolderma/article/view/344
[15]  Carreño-Fernandez, A.V. and Avella-Chaparro, D.A. (2021) Prevalencia de Acantosis Nigricans y factores asociados a Síndrome Metabólico en Nobsa-Boyacá. Revista Investigación en Salud Universidad de Boyacá, 8, 63-74.
https://doi.org/10.24267/23897325.625
[16]  Das, A., Datta, D., Kassir, M., Wollina, U., Galadari, H., Lotti, T., et al. (2020) Acanthosis Nigricans: A Review. Journal of Cosmetic Dermatology, 19, 1857-1865.
https://doi.org/10.1111/jocd.13544
[17]  Räßler, F., Goetze, S. and Elsner, P. (2017) Acrokeratosis Paraneoplastica (Bazex Syndrome)—A Systematic Review on Risk Factors, Diagnosis, Prognosis and Management. Journal of the European Academy of Dermatology and Venereology, 31, 1119-1136.
https://doi.org/10.1111/jdv.14199
[18]  Yamada, A., Umemoto, N., Demitsu, T. and Kitamura, O. (2024) Acrokeratosis Neoplastica (Bazex Syndrome): Report of Two Cases and Literature Review. Heliyon, 10, e26411.
https://doi.org/10.1016/j.heliyon.2024.e26411
[19]  Couselo-Rodríguez, C., Galego-Fernández, R. and Núñez-Fernández, M.J. (2024) Síndrome de Bazex con resolución completa tras tratamiento quirúrgico de carcinoma epidermoide de laringe. Actas Dermo-Sifiliográficas, 115, 86.
https://doi.org/10.1016/j.ad.2022.08.035
[20]  Cassard, L., Seraly, N., Riegert, M., Patel, A. and Fernandez, A. (2024) Dermatomyositis: Practical Guidance and Unmet Needs. ImmunoTargets and Therapy, 13, 151-172.
https://doi.org/10.2147/itt.s381472
[21]  Julita K Putri, W. (2023) Dermatomyositis: A Review of Diagnosis and Classification Criteria. International Journal of Science and Healthcare Research, 8, 42-48.
https://doi.org/10.52403/ijshr.20230407
[22]  Gore, M. and Winters, M. (2011) Erythema Gyratum Repens: A Rare Paraneoplastic Rash. Western Journal of Emergency Medicine, 12, 556-558.
https://doi.org/10.5811/westjem.2010.11.2090
[23]  Votquenne, N. and Richert, B. (2020) Erythema Gyratum Repens. JAMA Dermatology, 156, 912.
https://doi.org/10.1001/jamadermatol.2020.1694
[24]  Malek, A., Nasnas, P. and Nasnas, R. (2017) Erythema Gyratum Repens Secondary to Acute Myeloblastic Leukemia. Journal of Clinical & Experimental Dermatology Research, 8, Article ID: 1000406.
https://doi.org/10.4172/2155-9554.1000406
[25]  Qadan, M., Visser, B., Kim, J., Pai, R. and Triadafilopoulos, G. (2011) Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema. Digestive Diseases and Sciences, 57, 1465-1468.
https://doi.org/10.1007/s10620-011-1967-5
[26]  Wu, S., Bai, J., Xu, J., Ma, Q. and Wu, Z. (2014) Necrolytic Migratory Erythema as the First Manifestation of Pancreatic Neuroendocrine Tumor. World Journal of Surgical Oncology, 12, Article No. 220.
https://doi.org/10.1186/1477-7819-12-220
[27]  Rodríguez, G., Vargas, E., Abaúnza, C. and Cáceres, S. (2016) Eritema necrolítico migratorio y glucagonoma pancreático. Biomédica, 36, 176-181.
https://doi.org/10.7705/biomedica.v36i3.2723
[28]  Hernaiz Calvo, L.M., Abadías Granado, I., Sánchez Bernal, J., Abecia Martínez, E.I. and Gilaberte Calzada, Y. (2021) Escleredema: mÁs allá del endurecimiento de la piel. Medicina de Familia. Semergen, 47, 501-503.
https://doi.org/10.1016/j.semerg.2021.05.002
[29]  Gómez-Arias, P.J., Vélez García-Nieto, A.J. and Salido-Vallejo, R. (2021) Paraneoplastic Hypertrichosis Lanuginosa Acquisita. Indian Journal of Dermatology, Venereology and Leprology, 88, 525-526.
https://doi.org/10.25259/ijdvl_448_20
[30]  Slee, P.H.T.J., van der Waal, R.I.F., Schagen van Leeuwen, J.H., Tupker, R.A., Timmer, R., Seldenrijk, C.A., et al. (2007) Paraneoplastic Hypertrichosis Lanuginosa Acquisita: Uncommon or Overlooked? British Journal of Dermatology, 157, 1087-1092.
https://doi.org/10.1111/j.1365-2133.2007.08253.x
[31]  Ortiz-Pérez, D.F., Montoya-Jaramillo, M.E., Emiliani-Cortes, J.D., Flórez-Theran, K.P., Sierra-Tapia, K.A., Hernández-Salgado, M., et al. (2024) Leser-Trélat Associated with Myeloproliferative Neoplasia: When the Skin Speaks. Journal of Biosciences and Medicines, 12, 335-341.
https://doi.org/10.4236/jbm.2024.1212026
[32]  Tibaduiza Mogollon, Y.A., Miranda Diaz, A.J. and Navas Torrejano, D.S. (2019) Signo de Leser-Trélat, signo paraneoplásico en cáncer de mama metastásico: Presentación de caso. Revista Med, 26, 60-64.
https://doi.org/10.18359/rmed.3554
[33]  Safa, G. and Darrieux, L. (2011) Leser-Trélat Sign without Internal Malignancy. Case Reports in Oncology, 4, 175-177.
https://doi.org/10.1159/000327363
[34]  Fink, A., Filz, D., Krajnik, G., Jurecka, W., Ludwig, H. and Steiner, A. (2009) Seborrhoeic Keratoses in Patients with Internal Malignancies: A Case-Control Study with Prospective Accrual of Patients. Journal of the European Academy of Dermatology and Venereology, 23, 1316-1319.
https://doi.org/10.1111/j.1468-3083.2009.03163.x
[35]  Schwartz, R.A. (1996) Sign of Leser-Trelat. Journal of the American Academy of Dermatology, 35, 88-95.
https://doi.org/10.1016/s0190-9622(96)90502-2
[36]  Tirado-Sánchez, A. and Bonifaz, A. (2017) Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease: A Retrospective Study from a Tertiary Care Center in South India. Actas Dermo-Sifiliográficas, 108, 902-910.
https://doi.org/10.1016/j.ad.2017.04.024
[37]  Sathishkumar, D., Agrawal, P., Baitule, A.M., Thomas, M., Eapen, A., Kumar, S., et al. (2021) Paraneoplastic Autoimmune Multiorgan Syndrome. Indian Dermatology Online Journal, 12, 572-576.
https://doi.org/10.4103/idoj.idoj_640_20
[38]  Didona, D., Didona, B., Richetta, A.G., Cantisani, C., Moliterni, E., Calvieri, S., et al. (2015) Paraneoplastic Pemphigus: A Trait D’union between Dermatology and Oncology. Advances in Modern Oncology Research, 1, 97-103.
https://doi.org/10.18282/amor.v1.i2.42
[39]  Manrique, G., Herrera, L., Bustamante, I. and Ordóñez, M.F. (2017) Pitiriasis rotunda en Colombia. Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 25, 54-56.
https://doi.org/10.29176/2590843x.322
[40]  Andrea Londoño, P., Hernando Moreno, L. and Rueda, R. (2008) Síndrome de Sweet Sweet’ syndrome.
https://revista.asocolderma.org.co/index.php/asocolderma/article/view/160?time=1712825478
[41]  Villarreal-Villarreal, C.D., Ocampo-Candiani, J. and Villarreal-Martínez, A. (2016) Sweet Syndrome: A Review and Update. Actas Dermo-Sifiliográficas, 107, 369-378.
https://doi.org/10.1016/j.ad.2015.12.001

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133